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Abstract
Purpose: The purpose of this study is to evaluate the dosimetric uncertainty associated with Gafchromic™ (EBT3)
films and establish a practical and efficient film dosimetry protocol for Stereotactic Radiosurgery (SRS) and Stereotactic
Body Radiotherapy (SBRT).
Method and materials: EBT3 films were irradiated at each of seven different dose levels between 1 and 15 Gy with
open fields and standard deviations of dose maps were calculated at each color channel for evaluation. A scanner
non-uniform response correction map was built by registering and comparing film doses to the reference ion chamber
array-based dose map delivered with the same doses. To determine the temporal dependence of EBT3 films, the
average correction factors of different dose levels as a function of time were evaluated up to 4 days after irradiation.
An integrated film dosimetry protocol was developed for dose calibration, calibration curve fitting, dose mapping, and
profile/gamma analysis. Patient specific quality assurance (PSQA) was performed for 83 SRS/SBRT treatment plans, and
analysis of the measurements and calculations are presented here.
Results: The scanner response varied within 1 % for the field sizes less than 5 × 5 cm2, and up to 5 % for the field sizes
of 10 × 10 cm2 for all color channels. The scanner correction method was able to remove visually evident, irregular
detector responses for larger field sizes. The dose response of the film changed rapidly (~10 %) in the first two hours
and became smooth plateaued afterwards, ~3 % change between 2 and 24 h. The uncertainties were approximately
1.5, 1.7 and 4.8 % over the dose range of 3~15 Gy for the red, green and blue channels. The green channel
showed very high sensitivity and low uncertainty in the dose range between 10 and 15 Gy, which is suitable for
SRS/SBRT commissioning and PSQA. The difference between the calculated dose and measured dose of ion
chamber measurement at isocenter was −0.64 ± 2.02 for all plans, corresponding to a 95 % confidence interval of
(−1.09, −0.26). The percentage of points passing the 3 %/1 mm gamma criteria in absolute dose, averaged over
all tests was 95.0 ± 4.2.
Conclusion: We have developed the EBT3 films based dosimetry protocol to obtain absolute dose values.
The overall uncertainty has been established to be 1.5 % for SRS and SBRT PSQA.
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Introduction
Flattening Filter Free (FFF) modalities have been widely
used for Stereotactic Radiosurgery (SRS) and Stereotactic
Body Radiotherapy (SBRT) procedures, because of the
high dose rate, sharp penumbra, reduced leaf transmission
and head scatter associated with FFF beams [1–3].
Modern radiation therapy modalities, including intensity
modulated radiation therapy (IMRT) and volumetric mod-
ulated arc therapy (VMAT), produce SRS/SBRT plans
with highly irregular and steep dose gradient distributions.
IMRT/VMAT treatment beams are often heterogeneous
and complex, consisting of many small beam apertures re-
alized by a multi-leaf collimator (MLC). Accurate verifica-
tion of such complex treatment fields is challenging. The
conventional method for patient specific quality assurance
(PSQA) of measuring a point dose using an ionization
chamber (IC) or fluence using a two-dimensional (2D)
array is inadequate for highly modulated treatment fields
with sharp dose gradient fall off [4–6].
Gafchromic™ EBT3 film has been introduced to elim-
inate measurement orientation effects as well as Newton
rings formed during film scanning [7]. EBT3 Film dos-
imetry has been used most commonly for relative dose
analysis [8]. The absolute dose map is built by normaliz-
ing a selected reference point to the reading of a
dosimeter, which is inadequate for SRS and SBRT PSQA
considering the volume size of the dosimeters in general.
There has been no study to evaluate the characteristics
of EBT3 Gafchromic™ films on FFF beams and high
dose range in the SRS/SBRT dose regimen. This study
presents a practical and efficient film dosimetry proto-
col for SRS and SBRT PSQA using FFF photon beams.
Uncertainties associated with the film channels coupled




An Epson Expression 10000XL document flat-bed scan-
ner (Seiko Epson Corp, Nagano, Japan) was used to scan
the films. Each film was scanned in the center of the
scanner bed to allow for better scanner response uni-
formity [9] and in the landscape orientation with the
longer side of film parallel to the scanner detector array
(Fig. 1a) [10, 11]. To improve film placement reproduci-
bility and reduce orientation-dependent response varia-
tions, two film strips were attached to the scanner bed
and the shorter film side was aligned against the strip
(Fig. 1b) [12]. The film strips were used instead of an
opaque frame in order to provide similar light scattering
characteristics near the film borders. The films were
scanned in transmission mode for better scanning stability
[13, 14] with settings of 150 dot per inch and 48 bit RGB
mode (16 bits per color channel). Images were exported in
tagged image file format (TIFF) for analysis and image
processing filters were disabled.
Scanner Non-uniform response correction
A scanner non-uniform response correction is necessary
for the following reasons: each charge coupled device de-
tector of a document scanner has different sensitivity, the
light source may have non-uniform light intensity, and the
amount of scattered light photons also depends on the
film location on the scanner bed [11]. It has also been
found that the non-uniformity correction depends on the
delivered dose [11]. In this study, we designed a three di-
mensional correction map, which was a function of the
scanner bed position and the dose. Figure 2 shows the
flowchart of scanner non-uniform response correction.
For a given dose level, a solid water phantom (30 × 30 ×
15 cm3) was setup for irradiation with 5 cm thickness on
the top of the film and 10 cm thickness under the film for
backscatter. Under the same film irradiation conditions,
the reference doses were measured with a 2D ion chamber
array (MatriXX, IBA Dosimetry AB, Schwarzenbruck,
Germany). The irradiated films were scanned four
times and the optical density (OD) maps were averaged
from four film OD images. The MatriXX dose map was
normalized to the average OD values at the central
1 cm × 1 cm region. The average OD map was regis-
tered to the reference MatriXX dose map using an open
source image registration tool-kit, Elastix [15]. The
pixel-by-pixel correction factors were defined as from
the ratio of the OD maps from film to the correspond-
ing dose maps from the diode array. Since the dose
map, measured by the ion chamber array, has coarse
resolution (7.6 mm pixel-to-pixel distance), it was ne-
cessary to resample this map to match the film grid
resolution (0.17 mm). In order to minimize the ringing
artifact [16], linear interpolation was employed.
Dose response curve calibration
The mean OD values of central 5 × 5 mm2 area were
measured on all scanner non-uniformity corrected pre-
and post- irradiation. The netOD values were calculated
by subtracting the prescan OD values from the corre-
sponding post-scan OD values. The mean netOD and
OD values were then fitted to the corresponding refer-
ence doses to generate response curves using cubic B-
spline interpolation. The sensitivity was calculated for
each dose level by taking the first derivative of the dose re-
sponse curve. Each color channel image of the scanned
films was converted to dose using the correction map and
dose response curves.
Film dosimetry uncertainty
Optical density and netOD profiles were evaluated
from four film images for each of seven dose levels
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(1.0, 3.4, 5.3, 7.5, 9.7, 12.0, 15.0 Gy). Film uncertainty,
defined as the fluctuation in dose response across the
irradiated field, was evaluated by irradiating four films
with open fields at various dose levels. All three color
channel images from four film images were converted
to doses using both netOD-to-dose and OD-to-dose
response curves. Pixel–based dose error maps were
then calculated from the measured reference doses.
Standard deviations were calculated over the central
5 × 5 mm2 area for each film between the measured
and calculated dose. The root mean square of the
standard deviations was calculated over four different
films at three dose levels (3.4, 9.7 and 15.0 Gy) for










where xi is the difference between the measured and cal-
culated dose at pixel i, x is the average value of the dif-
ferences across 5 × 5 mm2.
Fig. 1 a film scanning orientation with the longer side of film aligned to the scanner detector array. b A bird’s eye view of film scanning
orientation with film strips attached for positioning accuracy. c Acrylic phantom for film dose calibration. d A calibration film irradiated with a
nine 2 × 2 cm2 square dose pattern. e The corresponding planar isodose distribution. f A mask pattern used to sample optical density values to
establish the calibration curve





σ21 þ σ22 þ σ23 þ σ24ð Þ
r
ð2Þ
where σi is the standard deviation between the measured
and calculated dose in the central 5 × 5 mm2 area of film
i (i = 1 to 4) and σrms is the root mean square of the
standard deviations.
The time dependency of the films blackening was eval-
uated using the film calibration dose patterns. EBT3
films from the two different batches were exposed using
the same calibration plan (Fig. 1e) and scanned at differ-
ent time points (0, 0.5, 1.5, 3.5, 7.5 h, 1, 2 and 4 days) to
acquire time dependent calibration curves.
Film dosimetry protocol
Film calibration
Figure 1c shows the reference dose measurement condi-
tions. The calibration plans were created for each photon
energy in an acrylic phantom (Brainlab, Heimstetten,
Germany). The phantom has two 30 × 30 × 5 cm3 slabs.
The ion chamber plug is drilled right below the surface of
the slab, where the distance from the center of plug to the
surface is 4.0 mm. Films were positioned in the middle of
the phantom with 100 cm SAD setup. Calibration
films were irradiated for each photon energy with a
nine 2 × 2 cm2 square dose pattern ranging from 2.5 to
23.3 Gy (Fig. 1d). The calibration plan was calculated
with five 2 × 2 cm2 fields shaped by the jaw using the
Anisotropic Analytical Algorithm (AAA) dose calcula-
tion algorithm (V11.031, Varian Medical Systems, Palo
Alto, CA) as shown in Fig. 1e.
The calibration film was scanned, converted to OD
image, and registered with the calculated dose plane
using a rigid registration based on mutual information.
The pixel values of the scanned images were converted
to OD images using the following equation:
OD ¼ − log pv=65535½ 1:00:1
  ð3Þ
The variable pv represents the pixel values of the
scanned image, which was in turn normalized by the
maximum pixel value of 65,535. It was then restricted to
the range [0.1, 1.0] to prevent the log function from gen-
erating very large or infinite numbers.
A binary mask pattern (Fig. 1f ) was applied to the reg-
istered film image for sampling. The sampled OD values
of each color channel were then paired with the calcu-
lated dose values to establish the calibration curve utiliz-
ing cubic polynomial least squares fitting. The reference
doses were also verified with a pin-point 31014 ion
chamber (PTW, Freiburg GmbH, Germany).
Fig. 2 Scanner non-uniform response correction flowchart. The films were irradiated in a solid water phantom at 5 cm depth and the dose distribution
was measured with MatriXX at the same setup. The OD images obtained from the films were registered to the normalized MatriXX dose map. The
scanner correction map was generated by taking the ratio of the film OD map to MatriXX dose map
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Patient specific quality assurance
Eighty-three SRS/SBRT treatments were performed on a
Linac based radiosurgery platform, the Edge, (Varian
Medical Systems, Palo Alto, CA) for both intracranial
and extracranial diseases. The breakdown of tumor sites
treated with SRS/SBRT techniques of the 83 patients in
our study were CNS (38 %), lung (24 %), spine (26 %),
GI (11 %), and adrenal glands (2 %). The target volume
(TV) ranged from 0.04 to 64.36 cc (metastasis) for CNS
sites. Median TV volume of SBRT lung patients was
31.59 cc (6.49–116.43 cc). The median TV volume of
spine metastases was 40.71 cc (4.72–136.59 cc).
The treatment plans were created in the Eclipse treat-
ment planning system using 6XFFF (1400 MU/min) or
10XFFF mode (2400 MU/min) and the couch model
was included in the dose calculation [17]. Treatment
techniques used were as follows: 83 % VMAT plans
(2.3 ± 0.6 number of arcs), 12 % IMRT plans (8.4 ± 1.7
number of treatment fields), and 5 % Dynamic Con-
formal Arc plans (3.8 ± 0.5 number of arcs). Dose was
delivered in a single fraction (10–18 Gy) for CNS site.
All lung cancer patients were treated with 48 Gy in four
fractions. All spine metastases patients were treated in a
single fraction with the dose ranging from 14 Gy (primary:
multiple myeloma) to 18 Gy (all other primary diagnosis).
The same acrylic phantom was used for PSQA. The
phantom was setup to measure the dose plane axially for
the spine cases to capture dose drop off from the vertical
body to the cord and coronally for other cases. For all
cases planned with IMRT or VMAT, a single ion cham-
ber measurement (pin point chamber 31014, PTW,
Freiburg GmbH, Germany) was made at the isocenter
and a film was placed between the slabs to measure
planar dose distributions (Fig. 1c). For single isocenter
multiple targets (SIMT) cases, both ion chamber and
film measurements were made for each target. The per-
cent dose difference ratio between ion chamber meas-
urement and calculation was defined as [(measured
dose − calculated dose) × 100 %/calculated dose]. The
percentage of points passing gamma based on absolute
dose difference was calculated over a region of interest
defined at 10 % of maximum dose using 3 %, 1 mm
distance-to-agreement criteria. The confidence limit is
defined as (│mean│ + 1.96 × standard error) so that
95 % of the data falls within the confidence limit [18].
A one-way ANOVA was used to evaluate if any of the
variables (volume size, treatment site, treatment deliv-
ery technique) had a statistically significant effect on
the point dose measurement and gamma index.
Results
Dose response curve calibration
Figure 3 shows the OD-to-dose (upper) and netOD-to-
dose (middle) response curves, as well as the sensitivity
as a function of dose (lower). The square dots are the
measured OD and netOD values, and the solid lines
are the fitted cubic B-spline curves. The red channel
sensitivity (defined as OD per unit change in dose) was
the highest among all channels in the low dose region,
< 10 Gy. The green channel sensitivity was similar to
the red channel in the dose range above 10 Gy. The
blue channel exhibited the lowest sensitivity in all cases.
Scanner correction
Figure 4 shows a 3D scanner non-uniform correction
map of the 20 × 20 cm2 field size at the 12 Gy dose level
for the green channel. The scanner response varied
within 1 % for the field sizes less than 5 × 5 cm2, up to
5 % for the field sizes of 10 × 10 cm2 and 18 % for the
field sizes of 20 × 20 cm2 for all color channels.
Fig. 3 Dose response curves of OD (upper) and netOD methods
(middle) and the sensitivity as a function of dose (lower). Cubic
B-spline was employed as interpolant (R2 = 1 for all the curves)
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Film uncertainty
Optical density vs. net optical density
Figure 5 shows the measured OD (left column) and
netOD (right column) profiles across the square field
centers along the charge-coupled device array direction.
The profiles generated from four film images were over-
laid at each of the 7 dose levels and evaluated separately
for each color channel. The red channel showed a strong
lateral dose dependence, which manifested at dose levels
above 5.3 Gy. The differences between the OD and
netOD variations were minimal. For the green channel,
the netOD variations were smaller than that of the red
channel, especially at the profile shoulders. The OD re-
sponse of the blue channel exhibited less fluctuation
than that of the netOD response. In addition, at a dose
level of 1 Gy, there was little difference between the OD
and netOD response curves for the blue channel.
Figure 6 shows the uncertainties of the films estimated
at three different dose levels for each color channel. The
blue channel presented the highest uncertainties for all
dose levels, ranging from 3.3 to 6.6 %. For the low dose
level at 3.4 Gy, the red channel presented the best accur-
acy, within 1.5 %. For the higher dose level at 9.7 Gy, the
red and green channel had comparable accuracy with an
uncertainty level at 1.5 %. For the dose level at 15.0 Gy,
a clinically important region for SRS, the uncertainty in
the red channel was increased to 1.7 %. The green chan-
nel was superior and reached an uncertainty of 1.4 %.
Time dependence
Figure 7 shows the average correction factors for differ-
ent dose levels as a function of time, normalized at 4 days
after exposure. The dose response of the film changed
rapidly (~10 %) in the first 2 h (see Fig. 7). The response
varied much more gradually after the first 2 h; 3 %
change was detected between 2 and 24 h, and another
3 % change occurred between 1 and 4 days. These trends
were consistent at the most sensitive regions of each
channel, i.e. 3–5 Gy for the red channel, 5–15 Gy for the
green channel and 12–15 Gy for the blue channel as
shown in Figure 6. For the blue channel, large variation
was observed in the correction factor response as a func-
tion of time, at a dose level of 1 Gy. The trends were
also consistent between two film batches.
Patient specific quality assurance summary
Figure 8 shows the ion chamber and film measurement
results for all plans. The average difference of point dose
between measured value using ion chamber and calcu-
lated dose from the planning system was −0.64 ± 2.02 for
all plans, corresponding to a 95 % confidence interval of
(−1.09, −0.26). The percentage of points passing the
3 %/1 mm gamma criteria, averaged over all tests was
95.0 % ± 4.2 %, with a corresponding 95 % confidence
interval between 94.2 and 95.9 %.
Figure 9 shows an example of film analysis of a QA
plan for the spine and lung phantom [Fig. 9 (a)] from
the Imaging and Radiation Oncology Core Houston
(IROC) for single isocenter multiple target irradiation re-
lated to protocols NRG BR001 and BR002. Six Gy was
prescribed to both lung and spine target with two arcs
using VMAT and 6XFFF following IROC planning
guidelines. The QA plan was calculated on the acrylic
phantom [Fig. 9 (b)] in both axial and coronal [Fig. 9 (d
& h)] orientations. The film placement was intended to
replicate the location of the film planes embedded in the
spine-lung IROC phantom. The dose difference ratio
measured with the pin point chamber was −1.7 %, −2.7
and 0.2 % in the spine, lung and cord region respectively.
The line profiles were compared between the calculated
Fig. 4 The 3D scanner non-uniform correction map of the 20 × 20 cm2 field size at the 12 Gy dose level for the green channel. The vertical scale
is normalized to 12 Gy
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and measured dose in the axial plane [Fig. 9 (e)] and the
coronal plane [Fig. 9 (i)].
Discussion
Gafchromic™ film has excellent spatial resolution and is
independent of beam angle, energy and dose rate [19].
This makes it suitable for a variety of commissioning
and PSQA tasks. However, several sources of uncertain-
ties associated with film dosimetry, such as scanner,
background, film uniformity, impact the dosimetric ac-
curacy. Film dosimetry has been used most commonly
for relative dose analysis. We systematically investigated
the dosimetric uncertainty of EBT3 films. Instead of
normalizing the film dose based on ion chamber meas-
urement, we were able to analyze the film based on
absolute dose directly. To improve the efficiency of
using Gafchromic™ film routinely for patient specific
QA, we have developed an integrated film dosimetry
protocol that converts OD values to dose, registers film
and planar dose and analyzes the profiles and gamma
values. The protocol ensures the consistency of film
dosimetric results with a clear understanding of the un-
certainties of the film dosimetry protocol.
We used the reference doses measured with the
MatriXX detector arrays to calculate the scanner pixel-by-
pixel non-uniform response correction. The spatial reso-
lution of the MatriXX was limited by the center-to-center
distance between the ion chambers. This problem and its
potential impact on quality assurance have been investi-
gated by several groups to validate the 2D detector array’s
Fig. 5 Horizontal (orthogonal to scan direction) OD and netOD profiles for dose levels of 1.0, 3.4, 5.3, 7.5, 9.7 12.0 and 15.0 Gy. The rows from top
correspond respectively to the red, green, and blue channels. Each line represents a profile from one of the four film images
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performance [20, 21]. Poppe et al. investigated the sample
frequency provided by different 2D arrays and the Nyquist
frequency for 1 × 1 cm2 field size and complex IMRT
fields. They illustrated that the spatial frequency was
not extended beyond 0.1 mm−1 and very low beyond
0.06 mm−1 [4]. Since the spatial frequency of the sampled
dose distribution did not exceed one half of the MatriXX
sampling frequency 0.085 mm−1, i.e. the Nyquist fre-
quency limitation was not violated, the spatial resolution
of the MatriXX was appropriate to measure the penumbra
region and sharp dose gradient drop off region for small
field sizes investigated in this study.
As part of our film dosimetry protocol OD to dose re-
sponse curve was applied directly. For both the red and
green channels, there were negligible differences be-
tween the OD and netOD methods, implying that the
OD and netOD methods produce the same dosimetric
accuracy. However, the profiles from the red channel
were skewed due to the scanner lateral dependence
artifact at the higher dose levels [22]. For the blue chan-
nel, lower doses (e.g. 1 Gy) were insufficient for captur-
ing differences between OD and netOD. Therefore, the
images from green channel were extracted and con-
verted to dose using pre-established calibration curves.
The dose maps were compared to the treatment plan-
ning dose matrix for subsequent profile and gamma ana-
lysis for routine SRS/SBRT PSQA.
Film non-uniformity is one of the largest sources of
uncertainty for EBT film-based dosimetry. The uncer-
tainties of the GafchromicTM EBT model have been pre-
viously reported in the literature. Battum et al. reported
that the uncertainty of 1.8 % was achievable up to a dose
range of 2.3 Gy using the red channel when the films
were scanned at the central location of the scanner bed
[23]. Devic et al. reported 1.5 % uncertainty using the
red channel in the dose range of 0~4 Gy [24]. Saur and
Frengen reported 2.5 % uncertainty at 2 Gy exposure
when scanned in the landscape mode [11] and uncertainty
Fig. 6 The uncertainty at the three dose levels for the red, green and blue channel
Fig. 7 The average correction factors of different dose levels as a function of time, normalized at 4 days after exposure. The starting time of each
scanning was recorded in hours
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was reduced to 1.7 % when films were scanned in the
portrait mode. Papaconstadopoulos et al. suggested a
two-color reflection scanning protocol for EBT3 film
dosimetry in the dose range of 0 to 8 Gy [25]. Red
channel was recommended for doses less than 2 Gy
with an accuracy level of 3.7 % and the green channel
for higher doses at an accuracy level of 5 %. However,
there have been lack of studies to evaluate the uncer-
tainties of EBT3 films for SRS/SBRT treatment. Our
study showed that the red channel has very high sensi-
tivity and low uncertainty in the low dose region
(<10 Gy) and that the green channel is best suited for
most SRS/SBRT prescription dose levels and the overall
uncertainty can be controlled at 1.5 %. This uncertainty
does not account for the dose response changes of the
films as a function of time.
In the time dependency study, the dose difference was
greater than 10 % if the film was scanned in the first 2 h
after delivery and within 3 % within 1 day thereafter.
Calibration curves should be generated at different time
periods considering PSQA workflow, such as 4 h for
same day delivery and scan, 20 h for the next day scan
and 2.5 days if the delivery is done on Friday night and
the film is scanned on Monday morning. In our study,
four cases did not pass 90 % gamma passing rate, which
triggered further evaluation. The passing rate based on
absolute dose analysis was 83.4 % (T6 spine), 71.3 % (T9
spine), and 87.6 % (lung, right upper lobe). When the
film results were normalized to ion chamber measure-
ments, the corresponding gamma passing rates based on
the relative dose analysis were 99.8, 99.7, and 99.6 %.
The failure of absolute dose analysis for all the cases was
due to the different development time between the cali-
bration and patient films. It is very important to incorp-
orate the impact of time dependent change on OD for
absolute dose analysis using GafchromicTM film.
Our film dosimetry protocol can improve QA effi-
ciency with a single measurement for both point and
planar, absolute dose distribution analysis. Our measure-
ments encompassed a variety of complexity in the SRS/
SBRT cases. No variables (volume size, treatment site,
treatment delivery technique) were found to have a sta-
tistically significant impact on the gamma index based
on by the one-way ANOVA test. Very limited data have
been reported on the SRS/SBRT PSQA using FFF beams
[26]. The established confidence limits reported from a
Fig. 8 a Percent point dose difference between measured (pin point chamber) and calculated dose (Eclipse); b The percentage of points passing
the gamma criteria of 3 %/1 mm using films based on absolute dose comparison
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large SRS/SBRT patient cohort can be subsequently ap-
plied for patient specific verification. The excellent
spatial resolution (0.2 mm) of the films, makes it ideal
for absolute dose profile analysis, as a means evaluate
plan delivery quality for highly modulated dose distribu-
tions or small target volumes, as commonly encountered
in SRS/SBRT treatments.
Conclusion
We have estimated the uncertainty of a film dosimetry
protocol using Gafchromic™ EBT3 films with a flat-bed
document scanner. Utilization of the red channel for low
dose range (<10 Gy) and the green channel for high dose
range produced the most accurate results in the SRS/
SBRT dose regimes. The overall uncertainty of approxi-
mately 1.5 % is achievable for the green channel using
the EBT3 films if the film delivery and processing is
rigorously controlled. The film dosimetry protocol we
established offers a highly efficient solution for absolute
dose commissioning and routine PSQA for SRS/SBRT
treatment procedures.
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Fig. 9 The upper row: a the spine and lung phantom from IROC for single ISO multiple target irradiation for NRG BR001 and BR002 protocol;
b Planned axial dose distribution at central level of 6XFFF Hard C-Shape plan using VMAT technique on the acrylic phantom; The middle row:
(c-d) Planned and measured dose distribution in the axial plane; e The dose profile comparison along the oblique line across both spine and lung
targets shown in (c); f film gamma analysis results with 3 %/1 mm criteria (99.4 % of pixels passed within region of interest shown in (c); The lower
row: The same comparisons in the coronal view. The film gamma pass rate with 3 %/1 mm criteria was 98.9 %
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